Kestra Private Wealth Services LLC Acquires 14,912 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)

Kestra Private Wealth Services LLC lifted its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS) by 105.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 29,106 shares of the company’s stock after purchasing an additional 14,912 shares during the period. Kestra Private Wealth Services LLC’s holdings in Hims & Hers Health were worth $704,000 as of its most recent filing with the SEC.

Other large investors also recently added to or reduced their stakes in the company. CWM LLC increased its stake in shares of Hims & Hers Health by 21.4% during the third quarter. CWM LLC now owns 5,982 shares of the company’s stock valued at $110,000 after buying an additional 1,054 shares during the period. Creative Planning boosted its position in shares of Hims & Hers Health by 18.1% in the 3rd quarter. Creative Planning now owns 25,925 shares of the company’s stock worth $478,000 after purchasing an additional 3,979 shares in the last quarter. nVerses Capital LLC boosted its holdings in Hims & Hers Health by 31.8% in the third quarter. nVerses Capital LLC now owns 14,100 shares of the company’s stock worth $260,000 after acquiring an additional 3,400 shares in the last quarter. Cadent Capital Advisors LLC purchased a new stake in Hims & Hers Health during the 3rd quarter valued at about $1,310,000. Finally, Means Investment CO. Inc. bought a new stake in shares of Hims & Hers Health during the third quarter valued at approximately $747,000. Hedge funds and other institutional investors own 63.52% of the company’s stock.

Insider Transactions at Hims & Hers Health

In other Hims & Hers Health news, COO Melissa Baird sold 58,750 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $21.04, for a total transaction of $1,236,100.00. Following the completion of the sale, the chief operating officer now directly owns 630,166 shares of the company’s stock, valued at approximately $13,258,692.64. This trade represents a 8.53 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Soleil Boughton sold 2,343 shares of Hims & Hers Health stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $29.90, for a total transaction of $70,055.70. Following the completion of the transaction, the insider now owns 165,254 shares in the company, valued at approximately $4,941,094.60. This trade represents a 1.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,111,554 shares of company stock worth $33,865,763. Insiders own 17.71% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently commented on the company. Deutsche Bank Aktiengesellschaft lifted their price objective on Hims & Hers Health from $23.00 to $27.00 and gave the stock a “hold” rating in a report on Wednesday, November 6th. Morgan Stanley assumed coverage on shares of Hims & Hers Health in a research report on Tuesday, December 17th. They set an “overweight” rating and a $42.00 price objective on the stock. TD Cowen reaffirmed a “buy” rating and set a $28.00 price objective on shares of Hims & Hers Health in a report on Wednesday, November 20th. Canaccord Genuity Group boosted their target price on Hims & Hers Health from $28.00 to $38.00 and gave the stock a “buy” rating in a research report on Monday, December 2nd. Finally, Piper Sandler increased their price objective on shares of Hims & Hers Health from $21.00 to $24.00 and gave the company a “neutral” rating in a research report on Monday, January 6th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, Hims & Hers Health has a consensus rating of “Hold” and a consensus target price of $25.13.

Hims & Hers Health Stock Up 2.1 %

Shares of NYSE HIMS opened at $60.41 on Friday. The business has a 50-day moving average price of $32.06 and a 200 day moving average price of $24.26. The stock has a market cap of $13.20 billion, a PE ratio of 137.31 and a beta of 1.35. Hims & Hers Health, Inc. has a 52-week low of $9.22 and a 52-week high of $64.84.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.